Xience V stent vs. Cypher stent in all-comer patients: A randomized trial.
Recruiting
- Conditions
- Patients with coronary artery disease undergoing percutaneous coronary intervention
- Registration Number
- NL-OMON26637
- Lead Sponsor
- Medisch Centrum Leeuwarden, Cardiologie poli 67Henri Dunantweg 28934 AD LeeuwardenThe Netherlands
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 2000
Inclusion Criteria
1. Patient is willing to sign the informed consent;
2. Patient is willing to perform all follow-up examinations as required by the protocol;
Exclusion Criteria
1. Patients who are minor, intravenous drug abusers, alcohol abuser, prisoners or unable to give informed consent;
2. Patients who are allergic to everolimus or sirolimus;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical MACE at 1 year (cardiac mortality, non-fatal myocardial infarction, TVR).
- Secondary Outcome Measures
Name Time Method 1. (Sub)-acute stent thrombosis (SAT) at 30 days and late stent thrombosis (LST) at 1, 2 and 3 year;<br /><br>2. Clinical MACE at 30 days and 2 and 3 years (cardiac death, non-fatal MI, TVR);<br /><br>3. All cause mortality at 1, 2 and 3 year.